LaTrobe University – Olivia Newton-John Cancer Research Institute
About
La Trobe University’s Olivia Newton-John Cancer Research Institute (ONJCRI) is at the frontier of cancer medicine discovery and clinical trials, providing patients with access to experimental and breakthrough treatments including immunotherapies, targeted therapies and personalised medicine.
We support national collaboration of researchers in university and medical research institutes with integrated molecular imaging programs that extend from laboratory research, including biology, chemistry, biotechnology, through to novel probe radiochemistry and validation in animal imaging (PET and MRI) prior to human trials.
The validation of PET probes developed in the cyclotron and radiochemistry facilities on this campus has led to the initiation of over 20 first-in-human and later stage clinical trials in multiple sites in Melbourne, as well as Sydney, Perth, Brisbane and Adelaide collaborative sites.
Location
Olivia Newton-John Cancer Centre
145 Studley Rd
Heidelberg VIC 3084
Node Director
Contact
Latest news
National Imaging Facility granted $28m NCRIS funding to strengthen Australia’s advanced imaging network and bolster health research
19 October 2023
Victorian collaboration raises over $50m investment in critical imaging capabilities
04 July 2023
Australian cancer patients to benefit from state-of-the-art ACRF Centre for Precision Medicine at the Olivia Newton-John Cancer Research Institute
18 December 2022
Cancer diagnosis and targeted therapies to flow from new NIF investment
08 September 2022